A survey among hospital specialists and pharmacists about biosimilars

被引:19
作者
Pasina, Luca [1 ]
Casadei, Gianluigi [1 ]
Nobili, Alessandro [1 ]
机构
[1] Ist Ric Farmacol Mario Negri, IRCCS, Milan, Italy
关键词
Biological agents; Biosimilars; Drug information; Regulatory;
D O I
10.1016/j.ejim.2016.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E31 / E33
页数:3
相关论文
共 9 条
[1]  
European Medicines Agency, SCI GUID BIOS MED
[2]  
Finnish Medicines Agency, AR BIOS INT
[3]   The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper [J].
Fiorino, Gionata ;
Girolomoni, Giampiero ;
Lapadula, Giovanni ;
Orlando, Ambrogio ;
Danese, Silvio ;
Olivieri, Ignazio .
AUTOIMMUNITY REVIEWS, 2014, 13 (07) :751-755
[4]  
Fodmark CE, 2013, BIOL THER, V3, P35
[5]  
Mellstedt Hakan, 2013, EJC Suppl, V11, P1, DOI 10.1016/S1359-6349(13)70001-6
[6]  
Park W, 2016, ANN RHEUM DIS
[7]  
Romer Tomasz, 2011, Biol Ther, V1, P5
[8]   New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer [J].
Thill, Marc .
EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) :331-338
[9]  
Yoo DH, 2016, ANN RHEUM DIS, V29